May 10, 2017 / 12:25 PM / 2 months ago

BRIEF-Wave Life Sciences posts Q1 net loss per share $0.89

2 Min Read

May 10 (Reuters) - Wave Life Sciences Ltd

* Wave Life Sciences reports first quarter 2017 financial results and provides business update

* Wave Life Sciences Ltd - two HD programs and DMD program remain on track to enter clinic in 2017

* Wave Life SciencesLtd - will announce our next three pipeline candidates later this year

* Wave Life Sciences Ltd - is on track to deliver six development programs by end of 2018

* Wave Life Sciences Ltd - research and development expenses were $14.7 million for Q1 of 2017 as compared to $4.7 million for same period in 2016

* Wave Life Sciences - expects cash, cash equivalents available as of March 31, 2017 will be sufficient to fund operating expenses and capital expenditure into mid-2019

* Wave Life Sciences Ltd - had cash and cash equivalents totaling $129.5 million as compared to $150.3 million as of december 31, 2016

* Wave Life Sciences Ltd qtrly revenue $676,000

* Wave Life Sciences Ltd qtrly net loss per share $0.89

* Q1 earnings per share view $-0.77, revenue view $645000.00 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below